Clinical Trial Update: Transurethral Resection and Combination Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating transurethral resection with combination chemotherapy for Stage II/III bladder cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer

Snippet

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC | Conditions: Bladder Cancer | Phase 2 | Status: TERMINATED